<unk>  (INN) is a uricosuric agent used in the treatment of gout, especially when allopurinol, a first-line treatment, fails or produces intolerable adverse effects. It is structurally related to the antiarrhythmic amiodarone.<unk>  is highly effective and well-tolerated, and clinical trials as early as 1981 and as recently as April 2008 have suggested it is superior to both allopurinol and probenecid, another uricosuric drug.
Benzbromarone
Indoramin
Drotebanol
Etafenone
Etozoline
Quinoline
Olaflur
Vindesine